RxDoctor Payments Data

Teresa Geisinger

Family · Temecula, CANPI 1811384365

Payments from drug & device makers

$7,027in general payments, 2019–2025

Across 304 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$719
  • Regeneron Healthcare Solutions, Inc.$402
  • Madrigal Pharmaceuticals$380
  • Sanofi$324
  • Ardelyx, Inc.$262
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,95199%
  • Education$761%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,027 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase47$267,972
ZenpepLipase/Protease/Amylase21$118,303
XifaxanRifaximin22$62,857
LinzessLinaclotide66$43,578
IbsrelaTenapanor Hcl14$24,837
Dexlansoprazole DrDexlansoprazole80$24,128
Rabeprazole Sodium287$10,181
TrulancePlecanatide14$8,450
ClenpiqSod Picosulf/Mag Ox/Citric Ac46$8,042
Colestipol Hcl61$6,059
Sucralfate11$3,138
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C21$3,014
Lubiprostone33$2,944
Famotidine250$2,859
Pantoprazole Sodium203$1,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$3,384$311,550113 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu$719$74,32157 claims
Ardelyx, Inc.Ibsrela$262$24,83714 claims
Ferring Pharmaceuticals Inc.Clenpiq$40$8,04246 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →